Yüklüyor......
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
OBJECTIVE: Most investigations of pharmacotherapy for treating Alzheimer's disease focus on patients with mild‐to‐moderate symptoms, with little evidence to guide clinical decisions when symptoms become severe. We examined whether continuing donepezil, or commencing memantine, is cost‐effective...
Kaydedildi:
| Yayımlandı: | Int J Geriatr Psychiatry |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5724694/ https://ncbi.nlm.nih.gov/pubmed/27739182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gps.4583 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|